Literature DB >> 28334859

Neurocognitive Function of School-aged HIV-infected Children in Enugu, Nigeria.

Kenechukwu K Iloh1,2, Ifeoma J Emodi1,2, Ngozi S Ibeziako1,2, Anthony N Ikefuna1,2, Agozie C Ubesie1,2, Ogochukwu N Iloh2, Gideon C Ilechukwu3, Adaeze C Ayuk1,2.   

Abstract

BACKGROUND: Evidence has shown neurocognitive problems often exist among human immunodeficiency virus (HIV)-infected children. There are limited data for children in Nigeria.
METHODS: This was a cross-sectional study of 100 school-aged perinatally HIV-infected children seen in the paediatric HIV clinic and age/sex-matched controls from the general paediatric clinic. Neuro-cognitive functioning was assessed using the Raven's progressive matrices (RPM) that has been adapted for the Nigerian population.
RESULTS: The mean RPM score of subjects was 22.97 ± 11.35 compared with 32.93 ± 15.71 among controls (p < 0.001). Twenty-two percent of subjects in the HIV-infected group vs. 56% of controls were in the above-average intelligence group on the RPM. Thirty-four percent had average scores, while 22% were in the below-average scoring range. Neuro-cognitive functioning of the subjects was significantly affected by immunologic staging and socio-economic status.
CONCLUSIONS: Neurocognitive functioning of the HIV-infected children was significantly lower than those of their un-infected counterparts. Neurodevelopmental evaluation should be part of standard care in HIV-infected children in Nigerian setting.
© The Author [2017]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; Nigeria; Raven; children; cognitive; functioning; neurocognitive; school-aged

Year:  2017        PMID: 28334859     DOI: 10.1093/tropej/fmx006

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  4 in total

1.  Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study.

Authors:  Damalie Nalwanga; Victor Musiime; Paul Bangirana; Erika Phelps Nishiguchi; Andrew Kiggwe; Titus Ssesanga; John M Ssenkusu; Philippa Musoke; Sarah E Cusick
Journal:  BMC Pediatr       Date:  2021-04-26       Impact factor: 2.125

Review 2.  Neurocognitive deficits and socioeconomic risk factors among children and adolescents living with HIV in sub-Saharan Africa: a systematic review.

Authors:  Otsetswe Musindo; Lydiah Krabbendam; Joan Mutahi; Miguel Pérez García; Paul Bangirana; Manasi Kumar
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2022-04-27       Impact factor: 7.494

3.  Positive and inverse correlation of blood lead level with erythrocyte acetylcholinesterase and intelligence quotient in children: implications for neurotoxicity.

Authors:  Nnenna Linda Nwobi; Solomon Kayode Adedapo; Olugbemi Olukolade; Opebiyi Alexander Oyinlade; Ikeoluwa Abiola Lagunju; Nnodimele Onuigbo Atulomah; Ikechukwu Ambrose Nwazuoke; John Ibhagbemien Anetor
Journal:  Interdiscip Toxicol       Date:  2020-02-20

4.  Academic performance and intelligence quotient of primary school children in Enugu.

Authors:  Uzoamaka Chinenye Akubuilo; Kenechukwu Kosisochukwu Iloh; Justus Uchenna Onu; Adaeze Chikaodinaka Ayuk; Agozie Chukwunedum Ubesie; Anthony Nnaemeka Ikefuna
Journal:  Pan Afr Med J       Date:  2020-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.